Striatal dopaminergic dysfunction in LRRK2 mutations models the progression of sporadic Parkinson's disease

被引：0
|
作者：
Agarwal, P.
Mak, E.
Schulzer, M.
Dinelle, K.
Aasly, J.
Hasegawa, K.
Wszolek, Z.
Zhang, J.
McKenzie, J.
Heffernan, N.
Farrer, M.
Sossi, V.
Stoessl, A. J.
机构：
来源：
MOVEMENT DISORDERS | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
121
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [41] Screening for LRRK2 mutations in patients with Parkinson's disease in Russia:: identification of a novel LRRK2 variant
    Pchelina, S. N.
    Yakimovskii, A. F.
    Emelyanov, A. K.
    Ivanova, O. N.
    Schwarzman, A. L.
    Singleton, A. B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (07) : 692 - 696
  • [42] Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson's Disease
    Ito, Genta
    Utsunomiya-Tate, Naoko
    BIOMOLECULES, 2023, 13 (05)
  • [43] An overview of the worldwide distribution of LRRK2 mutations in Parkinson's disease
    El Otmani, Hicham
    Daghi, Mohamed
    Tahiri Jouti, Nadia
    Lesage, Suzanne
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2023, 13 (06) : 335 - 350
  • [44] MIBG scintigraphy in Parkinson's disease with and without LRRK2 mutations
    Masso, J. F. Marti
    Martinez, J. Ruiz
    Bolano, M. J.
    Gorostidi, A.
    Marras, C.
    de Munain, A. J. Lopez
    MOVEMENT DISORDERS, 2008, 23 (01) : S254 - S255
  • [45] Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease
    Ben Sassi, Samia
    Nabli, Fatma
    Hentati, Emna
    Nahdi, Houda
    Trabelsi, Meriam
    Ben Ayed, Hela
    Amouri, Rim
    Duda, John Eric
    Farrer, Matthew John
    Hentati, Faycal
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (03) : 243 - 246
  • [46] Penetrance of LRRK2 mutations in familial Parkinson disease
    Nature Reviews Neurology, 2009, 5 (3) : 120 - 120
  • [47] Progression of dopaminergic dysfunction in a LRRK2 kindred A multitracer PET study
    Nandhagopal, R.
    Mak, E.
    Schulzer, M.
    McKenzie, J.
    McCormick, S.
    Sossi, V.
    Ruth, T. J.
    Strongosky, A.
    Farrer, M. J.
    Wszolek, Z. K.
    Stoessl, A. J.
    NEUROLOGY, 2008, 71 (22) : 1790 - 1795
  • [48] Role of LRRK2 kinase dysfunction in Parkinson disease
    Kumar, Azad
    Cookson, Mark R.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2011, 13 : e20
  • [49] Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibition
    Doggett, Elizabeth A.
    Zhao, Jing
    Mork, Christina N.
    Hu, Dongmei
    Nichols, R. Jeremy
    JOURNAL OF NEUROCHEMISTRY, 2012, 120 (01) : 37 - 45
  • [50] Low Levels of LRRK2 Gene Expression are Associated with LRRK2 SNPs and Contribute to Parkinson’s Disease Progression
    Selma Yılmazer
    Esin Candaş
    Gençer Genç
    Merve Alaylıoğlu
    Büşra Şengül
    Ayşegül Gündüz
    Hülya Apaydın
    Güneş Kızıltan
    Sibel Ertan
    Erdinç Dursun
    Duygu Gezen-Ak
    NeuroMolecular Medicine, 2021, 23 : 292 - 304
12345